South Korea Pharmaceutical Market Outlook 2013...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
3 South Korea Pharmaceutical Market Outlook 2013 – Overview 10
3.1 Global Pharmaceutical Industry Landscape 10
3.2 Macroscopic View of the South Korea Pharmaceutical Market 10
3.3 Trade Balance 12
3.3.1 Exports 13
3.3.2 Imports 16
3.4 Demographic Analysis 18
3.4.1 Population Size, Growth, and Structure 18
3.4.2 Crude Death Rate 19
3.4.3 Causes of Death 20
3.4.4 Crude Birth Rate 22
3.4.5 Infant Mortality Rate 23
3.4.6 Life Expectancy at Birth 24
3.4.7 Comparison of Healthcare Indicators 25
3.5 Driver and Barriers of South Korean Pharmaceutical Industry 26
3.5.1 Drivers 26
3.5.2 Barriers 28
4 South Korea Pharmaceutical Market Outlook 2013 – Industry Characteristics 29
4.1 Regulatory Agencies 29
4.1.1 Korea Food and Drug Administration 29
4.1.2 National Institute of Food and Drug Safety Evaluation 30
4.2 Drug Pricing Policy 31
4.3 Healthcare Expenditure in South Korea 32
4.4 Healthcare Infrastructure 37
4.5 Insurance and Reimbursement 38
4.5.1 National Health Insurance 38
4.5.2 Long-term Care Insurance 39
4.5.3 Medical Aid 40
5 South Korea Pharmaceutical Market Outlook 2013 – Market Analysis 41
5.1 Over-the-Counter drugs 41
5.2 Prescription Drugs 42
5.2.1 Patented Drugs 43
5.2.2 Generics 44
5.3 Biotechnology 45
6 South Korea Pharmaceutical Market Outlook 2013 – Key Trends 48
6.1 Rapid Consolidations in the Domestic Market 48
6.1.1 M&A deals 48
6.1.2 Partnership Deals 50
6.1.3 Licensing Deals 51
6.2 Understanding Local Markets to Build R&D 52
6.3 Free Trade Agreements 53
6.3.1 Intellectual Property Rights Protection 54
6.3.2 Transparency in Healthcare Regulatory and Reimbursement Process 54
6.3.3 Unethical Business Practices 54
7 South Korea Pharmaceutical Market Outlook 2013 – Competitive Landscape 55
7.1 Key Foreign Companies 55
7.1.1 GlaxoSmithKline 55
7.1.2 Sanofi 55
7.1.3 Pfizer 56
7.2 Key Domestic Companies 57
7.2.1 Dong-A 57
7.2.2 Green Cross 58
7.2.3 Hanmi 59
7.2.4 JW Holdings Corporation (Choongwae Holdings Co., Ltd.) 60
7.2.5 Yuhan Corporation 60
8 South Korea Pharmaceutical Market Outlook 2013 – The Way Forward 61
8.1 Outlook 61
8.2 Opportunities Ahead 61
8.2.1 Biosimilars 61
8.2.2 Stem Cell Research 61
9 South Korea Pharmaceutical Market Outlook 2013 – Appendix 63
9.1 Market Definitions 63
9.2 Abbreviations 63
9.3 Bibliography 64
9.4 Research Methodology 66
9.4.1 Coverage 66
9.4.2 Secondary Research 66
9.4.3 Primary Research 66
9.4.4 Expert Panel Validation 67
9.5 Contact Us 67
9.6 Disclaimer 67